10+
Installationen · ≈30
—
0 Bewertungen
2025-03-14
erste Veröffentlichung
2025-03-14
letzte Aktualisierung
Beschreibung
This app is specifically intended for participants in the GSK 221458 study only
This app is specifically intended for participants in the GSK 221458 study only.
It contains Televisit functionality and allows participants to complete questionnaires.
The study is a Phase 1, first-time-in-human, three-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of GSK4527363 in healthy participants (Part A), participants with active systemic lupus erythematosus (Part B), and healthy participants of Chinese and Japanese descent (Part C).
(Televisit tasks are not enabled by default and may be enabled as needed, by study officials.)
Neuigkeiten
Initial release
Details
| Version | 5.4.800.15-prod |
|---|---|
| Mindestversion Android | 8.0 |
| Rezensionen | 0 |
| Verfügbar in | Argentinien, Amerikanisch-Samoa, Bulgarien, Brasilien, Kanada, Spanien, Vereinigtes Königreich, Guam, Marshallinseln, Nördliche Marianen, Polen, Puerto Rico und 4 weitere |
| Entwicklerkontakte | im Business-Tarif |
| Erfasst | 2026-11-14 |
Diese Daten in der API
Der vollständige Eintrag als JSON kostet 1 Token.
curl -H "X-API-Key: YOUR_KEY" \ "https://apkapi.com/api/v1/app?id=com.medable.gsk221458"
